Agenda focus
Driven by demographic changes, technological advances and the transformation of healthcare systems, the life sciences and healthcare sector is emerging as one of the most strategically important sectors globally, for both governments and investors. Europe and China possess strong complementary advantages in life sciences research, industrial ecosystems and market scale, offering expanding opportunities for cooperation and long-term investment collaboration.
This forum will bring together investors, life sciences companies and innovation platforms from China and Europe to explore frameworks for cross-border investment cooperation, pathways for industrialization and commercialization, and collaboration in the life sciences sector. The dialogue aims to promote the development of a sustainable China–Europe investment cooperation network in life sciences and healthcare that benefits society globally.
Speakers
- William Stevens, Group Managing Director, Tech Tour
- Andreas Heyl, Chief Technology Officer, Formo Foods GmbH
- Diana Saraceni, General Partner, Panakes Partners
- Liisa Hurme, President and Chief Executive Officer, Orion Corporation
- Christophe Bavière, Co-Chief Executive Officer, Eurazeo
- Puneet Saraf, Chief Executive Officer, Phillips Corporate Venturing
- Angelo De Rosa, Global Vice President, CRMDx, Boston Scientific
- Dechao Yu, Founder, Chairman and Chief Executive Officer, Innovent Biologics
- Nisa Leung, Managing Partner, Qiming Venture Partners
- David Braun, Head, Global Digital Health, Merck Group
- Michael Brandkamp, Co-Founder and Managing Partner, European Circular Bioeconomy Fund (ECBF)
- Assaf Barnea, Founder and Chief Executive Officer, Sanara Ventures
